Ingevity Inkomsten in het verleden

Verleden criteriumcontroles 0/6

De winst van Ingevity is gedaald met een gemiddeld jaarlijks percentage van -45%, terwijl de winst van de Chemicals -industrie jaarlijks groeide met 11.1%. De inkomsten zijn groeide met een gemiddeld percentage van 6.9% per jaar.

Belangrijke informatie

-45.0%

Groei van de winst

-44.9%

Groei van de winst per aandeel

Chemicals Groei van de industrie	12.9%
Inkomstengroei	6.9%
Rendement op eigen vermogen	-262.8%
Nettomarge	-38.1%
Laatste winstupdate	30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 03

Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky

Jul 13

Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?

Jun 14

Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Apr 18

Is Ingevity (NYSE:NGVT) A Risky Investment?

Mar 22

What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Jan 23

Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

Jan 04

These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Nov 10

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Oct 07

Ingevity Corporation: The Risk To Reward Is Currently Favorable

Oct 06

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Sep 22

Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?

Aug 11

Ingevity Corporation: Headwinds Are Temporary

Jul 05

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Jun 21

Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

May 29

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Feb 16

Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?

Jan 25

Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Sep 13

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Aug 22

Ingevity to acquire pavement marking materials business Ozark Materials for $325M

Aug 02

Ingevity (NYSE:NGVT) Seems To Use Debt Quite Sensibly

Aug 01

Ingevity (NYSE:NGVT) Will Want To Turn Around Its Return Trends

Jun 05

What Does Ingevity Corporation's (NYSE:NGVT) Share Price Indicate?

May 20

Ingevity: Well-Diversified ESG Chemicals Company To Put On Watchlist

May 03

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

May 02

Opbrengsten en kosten

Hoe Ingevity geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NYSE:NGVT Opbrengsten, kosten en inkomsten (USD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
30 Sep 24	1,479	-564	171	28
30 Jun 24	1,548	-431	172	29
31 Mar 24	1,640	-112	183	30
31 Dec 23	1,692	-5	184	32
30 Sep 23	1,704	127	196	32
30 Jun 23	1,740	177	210	32
31 Mar 23	1,678	202	207	32
31 Dec 22	1,668	212	198	30
30 Sep 22	1,621	225	191	30
30 Jun 22	1,516	146	181	29
31 Mar 22	1,454	130	179	27
31 Dec 21	1,392	118	179	26
30 Sep 21	1,381	135	169	25
30 Jun 21	1,336	209	160	24
31 Mar 21	1,248	185	151	23
31 Dec 20	1,216	181	150	23
30 Sep 20	1,194	180	153	22
30 Jun 20	1,222	170	159	21
31 Mar 20	1,304	206	163	21
31 Dec 19	1,293	184	163	20
30 Sep 19	1,268	182	158	20
30 Jun 19	1,219	171	152	21
31 Mar 19	1,175	161	145	22
31 Dec 18	1,134	169	133	22
30 Sep 18	1,085	169	125	22
30 Jun 18	1,037	153	116	21
31 Mar 18	989	138	107	20
31 Dec 17	972	127	107	20
30 Sep 17	954	94	104	19
30 Jun 17	942	53	103	18
31 Mar 17	927	45	100	18
31 Dec 16	908	35	96	18
30 Sep 16	898	34	93	13
30 Jun 16	902	64	95	9
31 Mar 16	919	66	105	5
31 Dec 15	958	80	93	17
30 Sep 15	999	99	107	8
30 Jun 15	1,025	115	108	8
31 Mar 15	1,022	121	104	8
31 Dec 14	1,036	129	108	0
31 Dec 13	980	119	92	11

Kwaliteitswinsten: NGVT is momenteel verliesgevend.

Groeiende winstmarge: NGVT is momenteel verliesgevend.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: NGVT is verliesgevend en de verliezen zijn de afgelopen 5 jaar toegenomen met een snelheid van 45% per jaar.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van NGVT over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: NGVT is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Chemicals industrie ( -3.7% ).

Rendement op eigen vermogen

Hoge ROE: NGVT heeft een negatief Return on Equity ( -262.8% ), omdat het momenteel verliesgevend is.

Ingevity Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Third quarter 2024 earnings: EPS misses analyst expectations

Ingevity Corporation to Report Q2, 2024 Results on Jul 31, 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Ingevity Corporation to Report Q1, 2024 Results on May 01, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Ingevity Corporation to Report Q4, 2023 Results on Feb 21, 2024

Recent updates

Third quarter 2024 earnings: EPS misses analyst expectations

Ingevity Corporation Reaffirms Financial Guidance for the Full Year 2024

Is Ingevity (NYSE:NGVT) A Risky Investment?

Ingevity Announces Chief Executive Officer Changes

Ingevity Corporation's (NYSE:NGVT) Prospects Need A Boost To Lift Shares

Ingevity: The Risk-Reward Ratio Is Still Unfavorable

Price target decreased by 7.5% to US$49.60

Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Price target decreased by 9.7% to US$52.00

Ingevity Corporation Revises Earnings Guidance for the Full Year 2024

Ingevity Corporation to Report Q2, 2024 Results on Jul 31, 2024

Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky

Ingevity Corporation(NYSE:NGVT) dropped from Russell 2000 Growth-Defensive Index

Ingevity Corporation Announces Executive Changes

Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?

Price target increased by 7.4% to US$62.14

Ingevity Corporation Reiterates Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Ingevity Corporation to Report Q1, 2024 Results on May 01, 2024

Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Is Ingevity (NYSE:NGVT) A Risky Investment?

Ingevity Corporation Announces Resignation of William J. Slocum from Board

Ingevity Corporation, Annual General Meeting, Apr 23, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Ingevity Corporation Provides Earnings Guidance for the Year 2024

Ingevity Corporation to Report Q4, 2023 Results on Feb 21, 2024

What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Price target decreased by 8.9% to US$53.29

Consensus EPS estimates fall by 13%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 11% to US$58.50

Ingevity Corporation to Report Q3, 2023 Results on Nov 01, 2023

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Ingevity Corporation: The Risk To Reward Is Currently Favorable

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?

Consensus EPS estimates fall by 29%

Now 20% undervalued after recent price drop

Price target decreased by 8.9% to US$69.14

New major risk - Financial position

Second quarter 2023 earnings: EPS misses analyst expectations

Ingevity Corporation to Report Q2, 2023 Results on Aug 02, 2023

Ingevity Corporation: Headwinds Are Temporary

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Investor sentiment improves as stock rises 16%

Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

Consensus EPS estimates fall by 13%

Investor sentiment deteriorates as stock falls 20%

Price target decreased by 8.5% to US$88.71

Ingevity Corporation Announces Sales Guidance for 2023

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Insider recently sold US$117k worth of stock

Consensus EPS estimates fall by 11%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

Ingevity Corporation to Report Q4, 2022 Results on Feb 27, 2023

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?

Insider recently sold US$67k worth of stock

Insider exercised options and sold US$54k worth of stock

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ingevity Corporation Provides Earnings Guidance for the Year 2022

Ingevity Corporation to Report Q3, 2022 Results on Nov 02, 2022

Ingevity Corporation (NYSE:NGVT) acquired Ozark Logistics, LLC and Ozark Materials, LLC from Ozark Holdings, Inc. for approximately $330 million.

Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Ingevity Corporation (NYSE:NGVT) reached an agreement to acquire Ozark Logistics, LLC and Ozark Materials, LLC from Ozark Holdings, Inc. for approximately $330 million.

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat